Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

Summary 415 million people live with diabetes worldwide, and an estimated 193 million
people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients …

Background Early treatment intensification leading to sustained good glycaemic control is
essential to delay diabetic complications. Although initial combination therapy has been …

OBJECTIVE Diabetes mellitus (DM) increases the risk of infections, but the effect of better
control has not been thoroughly investigated. RESEARCH DESIGN AND METHODS With …

The American Diabetes Association, JDRF, the European Association for the Study of
Diabetes, and the American Association of Clinical Endocrinologists convened a research …

Aims Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely
manner according to evidence‐based clinical guidelines, is a key reason for uncontrolled …

Objective To investigate trends in incident and prevalent diagnoses of type 2 diabetes
mellitus (T2DM) and its pharmacological treatment between 2000 and 2013. Design …

Importance Treatment advances in diabetes can meaningfully improve outcomes only if they
effectively reach the populations at risk. Objectives To evaluate whether the cascade of US …

Poor glycaemic control in type 2 diabetes (T2D) is a global problem despite the availability
of numerous glucose‐lowering therapies and clear guidelines for T2D management …

Choices for the treatment of type 2 diabetes mellitus (T2DM) have multiplied as our
understanding of the underlying pathophysiologic defects has evolved. Treatment should …